Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 28;26(1):178–190. doi: 10.1093/neuonc/noad130

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

PMC Copyright notice

Figure 1. — Cohort composition and key clinical outcome. (A) The cohort was assembled from a multicenter study, SJYC07 and an NPTP cohort. Patients were included based on histology at diagnosis or treatment initiation. Treatment was divided into low and high-risk categories for SJYC07 and low-like, high-like, and other categories for NPTP patients. (B) EFS and OS of the whole study cohort (N = 56). (C) EFS and OS based on treatment categories for SJYC07 patients (N = 41). (D) EFS and OS based on treatment categories for the whole cohort (N = 56).